| dbo:abstract
|
- Lysophosphatidylinositol (LPI) ist das Lysophosphatid des Phosphatidylinositol-4,5-bisphosphats. (de)
- Lysophosphatidylinositol (LPI, lysoPI), or L-α-lysophosphatidylinositol, is an endogenous lysophospholipid and endocannabinoid neurotransmitter. LPI, along with its 2-arachidonoyl- derivative, (2-ALPI), have been proposed as the endogenous ligands of GPR55. (en)
|
| dbo:iupacName
|
- [(2R)-2-hydroxy-3-[hydroxy-[(2R,3R,5S,6R)-2,3,4,5,6-pentahydroxycyclohexyl]-oxyphosphoryl]oxypropyl] hexadecanoate (en)
|
| dbo:thumbnail
| |
| dbo:wikiPageID
| |
| dbo:wikiPageLength
|
- 3278 (xsd:nonNegativeInteger)
|
| dbo:wikiPageRevisionID
| |
| dbo:wikiPageWikiLink
| |
| dbp:imagefile
|
- Lysophosphatidylinositol.svg (en)
|
| dbp:imagesize
| |
| dbp:iupacname
|
- [-2-hydroxy-3-[hydroxy-[-2,3,4,5,6-pentahydroxycyclohexyl]-oxyphosphoryl]oxypropyl] hexadecanoate (en)
|
| dbp:wikiPageUsesTemplate
| |
| dcterms:subject
| |
| gold:hypernym
| |
| rdf:type
| |
| rdfs:comment
|
- Lysophosphatidylinositol (LPI) ist das Lysophosphatid des Phosphatidylinositol-4,5-bisphosphats. (de)
- Lysophosphatidylinositol (LPI, lysoPI), or L-α-lysophosphatidylinositol, is an endogenous lysophospholipid and endocannabinoid neurotransmitter. LPI, along with its 2-arachidonoyl- derivative, (2-ALPI), have been proposed as the endogenous ligands of GPR55. (en)
|
| rdfs:label
|
- Lysophosphatidylinositol (de)
- Lysophosphatidylinositol (en)
|
| owl:sameAs
| |
| prov:wasDerivedFrom
| |
| foaf:depiction
| |
| foaf:isPrimaryTopicOf
| |
| is dbo:wikiPageDisambiguates
of | |
| is dbo:wikiPageRedirects
of | |
| is dbo:wikiPageWikiLink
of | |
| is foaf:primaryTopic
of | |
